Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 4

1(20.0%)

Phase 3

1(20.0%)

5Total

N/A(3)

Phase 4(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT07243704Phase 3Not Yet Recruiting

Reducing the Burden of Cardiovascular Events With Antiplatelet Therapy in Patients With IntraCerebral Haemorrhage

Role: collaborator

NCT05836831Phase 4Recruiting

Indian Trial of Tranexamic Acid in Spontaneous Intracerebral Haemorrhage

Role: collaborator

NCT01272154Not ApplicableCompleted

Cerebellum and Cortical Plasticity: the Case of Dystonia

Role: collaborator

NCT02771873Not ApplicableCompleted

Programme of Lifestyle Intervention in Families for Cardiovascular Risk Reduction

Role: collaborator

NCT03555474Not ApplicableCompleted

Efficacy of the Theta Burst Stimulation and Functional Electrical Stimulation in Stroke Rehabilitation

Role: lead

All 5 trials loaded